We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App




Reference Intervals for Liver Function Tests Established for Minors

By LabMedica International staff writers
Posted on 04 Feb 2021
The liver is a large and complex organ that plays a central role in carbohydrate, protein, and fat metabolism. More...
Liver function tests can reflect the degree of damage to human liver parenchyma, fibrosis, synthesis status, and coagulation function.

The clinical interpretation of pediatric reference intervals (RIs) is executed in the context of age‐ and sex‐specific dynamics. Children and adolescents differ greatly from adults in terms of growth, development, and eating habits, so adult RIs are no longer applicable to the pediatric population.

Laboratory Medical Scientists at the First Hospital of Jilin University (Changchun, China) prospectively recruited 6,322 children and adolescents, ages ranged from 1 to less than 18 years from August 2017 to November 2018. Among the participants, 49.3% (3,119/6,322) were males and the male to female ratio is 1:1.03.

Serum samples were collected from all participants after overnight fasting for more than eight hours (3–6 hours under 3 years old), blood was taken between 7:30 and 9:30 in the morning by professional nurses, according to standard operating procedures. The measurements of biochemical analytes were run with Ortho VITORS 5600 (Ortho Clinical Diagnostic, Raritan, NJ, USA), a dry versatile chemistry system.

The scientists reported that age and sex differences were present in all analytes except serum total protein. The serum albumin ALB), total protein (TP), γ‐glutamyl transferase (GGT), total bilirubin (TBIL), and unconjugated bilirubin (Bu) levels increased with age while serum aspartate aminotransferase (AST) was the converse. The serum alanine aminotransferase (ALT) level reached a trough at the age of five and later steadily in males, but slowly decreased in females. The serum alkaline phosphatase (ALP) level dropped rapidly after reaching a peak at nine years old in females and 12 years old in males.

The authors concluded that many analytes showed age or sex differences, especially in puberty. ALP presented complex partition of RI (11 groups). The levels of serum ALB, TP, GGT, TBIL, direct bilirubin (DBIL), and Bu increased with age, while serum ALT, AST and ALP showed complicated trends. The study was published on January 22, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
First Hospital of Jilin University
Ortho Clinical Diagnostic



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.